- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/10 - Thiophene
Patent holdings for IPC class C07D 333/10
Total number of patents in this class: 180
10-year publication summary
|
16
|
12
|
9
|
13
|
5
|
10
|
7
|
9
|
9
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2141 |
7 |
| Avoscience, LLC | 12 |
5 |
| Sumitomo Chemical Company, Limited | 8992 |
4 |
| Korea Institute of Science and Technology | 2272 |
4 |
| Texas Heart Institute | 119 |
4 |
| Autophagysciences, Inc | 5 |
4 |
| Bristol-myers Squibb Company | 4756 |
3 |
| The Regents of the University of California | 20989 |
3 |
| The Johns Hopkins University | 5967 |
3 |
| Richter Life Science Development AB | 9 |
3 |
| Daegu-gyeongbuk Medical Innovation Foundation | 116 |
3 |
| Agency for Science, Technology and Research | 3786 |
2 |
| Board of Regents of The Nevada System of Higher Education, on Behalf of The University of Nevada, Reno | 132 |
2 |
| CHDI Foundation, Inc. | 108 |
2 |
| Chinese PLA General Hospital | 49 |
2 |
| Givaudan SA | 1990 |
2 |
| Insmed Incorporated | 290 |
2 |
| KEMET Electronics Corporation | 319 |
2 |
| Melinta Therapeutics, Inc. | 47 |
2 |
| National University Corporation Hokkaido University | 1387 |
2 |
| Other owners | 119 |